High-Precision Radiation Therapy

Excellence
In Oncology

We pioneer the future of cancer treatment with
Magnetic Precision Radiation Therapy (MPRT).

RADEXEL represents the convergence of Radiation and Excellence.

We are setting a new paradigm in cancer treatment by developing magnetic-controlled radiation therapy systems,

powered by the world’s first magnetic-radiation fusion technology and AI-driven precision treatment planning.

Radexel is pioneering a fusion solution that combines radiation therapy with advanced magnetic control technology.
We are building an optimized medical device ecosystem tailored to diverse clinical needs: the 'Modular Add-on (MPRT-SD)' for upgrading existing systems,
the 'Integrated All-in-One (MPRT-IS)' for complete treatment solutions,
and the 'Robotic System (MPRT-RB)' for precise, targeted therapy.

Cost Efficiency & Accessibility
Maximizing Efficiency

We aim to resolve the challenges of high acquisition costs and limited efficiency associated with modern radiation therapy systems. High costs often restrict patient access to necessary treatments. Radexel is driving technological innovation to enhance cost-efficiency, creating an environment where more patients can receive timely and effective care.

Precision & Safety
Targeting via Magnetic Control

Our Magnetic-Radiation Fusion Technology controls the path and distribution of radiation beams using magnetic fields. This system is designed to concentrate the radiation dose precisely on the tumor while minimizing exposure to surrounding healthy organs. We aim to deliver superior precision compared to conventional methods while alleviating the economic burden on patients.

Technology Leadership
Robust IP Portfolio & Validation

Radexel holds the world’s largest portfolio of foundational patents in magnetic-radiation fusion therapy. We have successfully completed prototype development and pre-clinical validation, proving the feasibility of our technology. As a global frontrunner, we are now focused on refining and advancing this cutting-edge technology.

Up to

0%*

Dose Reduction Healthy Tissue Sparing

0+

Global Patents Core Patents Held

0M+

Total Funding($) Investment & R&D Grants

* Dose reduction data is based on phantom studies and pre-clinical trials comparing Radexel’s magnetic control technology with conventional photon beam therapy (IMRT).

MPRT-SD

Modular Add-on Solution

Designed to expand the horizons of radiation therapy. This modular design is intended to be compatible with standard equipment, aiming to allow for functional upgrades without the need for full system replacement.

MPRT-RB

Mobile Robotic System

A robotic therapy system engineered to overcome spatial constraints. With its compact design and mobility, it is designed to deliver precise, localized targeting in diverse medical environments.

MPRT-IS

Integrated All-in-One System

A fully integrated system. The radiation source and magnetic control module are unified, designed to deliver optimal precision treatment immediately upon installation.

* The products depicted herein are currently under development and have not been cleared or approved by the FDA or other regulatory agencies. They are labeled for investigational use only and are not available for commercial sale.

Planning

Feasibility

Development

Validation

Approval

MPRT-SD

(Module)

Approval Stage

MPRT-RB

(Robotic)

In Development

MPRT-IS

(System)

In Development

Excellence In Oncology

Excellence
In Oncology